Alnylam Pharmaceuticals Taxes Paid increased by 85.5% to $2.37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.2%, from $2.97M to $2.37M. Over 2 years (FY 2022 to FY 2024), Taxes Paid shows an upward trend with a 132.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Significant divergence from income statement tax expense can signal timing differences, tax credits, or the impact of international tax strategies.
The actual amount of cash disbursed to tax authorities for corporate income taxes during the period, as opposed to the a...
Global corporations often have complex cash tax profiles due to varying international tax jurisdictions and repatriation activities.
income_taxes_paid| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $663.50K | $663.50K | $663.50K | $663.50K | $1.51M | $1.51M | $1.51M | $1.51M | $1.99M | $1.57M | $4.61M | $6.19M | $2.97M | -$1.87M | $1.28M | $2.37M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +126.9% | +0.0% | +0.0% | +0.0% | +32.0% | -20.8% | +192.7% | +34.4% | -52.1% | -163.0% | +168.3% | +85.5% |
| YoY Change | — | — | — | — | +126.9% | +126.9% | +126.9% | +126.9% | +32.0% | +4.6% | +206.1% | +311.4% | +49.4% | -218.9% | -72.3% | -20.2% |